Deficient interleukin-2 responsiveness of T lymphocytes from patients with primary biliary cirrhosis
✍ Scribed by José Luis Menéndez; José Antonio Girón; Luis Manzano; Aurelio Garrido; Luis Abreu; Agustin Albillos; Alberto Durántez; Melchor Alvarez-Mon
- Publisher
- John Wiley and Sons
- Year
- 1992
- Tongue
- English
- Weight
- 594 KB
- Volume
- 16
- Category
- Article
- ISSN
- 0270-9139
No coin nor oath required. For personal study only.
✦ Synopsis
There is increasing evidence that primary biliary cirrhosis is associated with an alteration of the immune system. Although the cause remains unknown, it has been suggested that the immune system of patients with primary biliary cirrhosis is involved in the pathogenesis of their disease. We have investigated the T-cell function in patients with primary biliary cirrhosis and have found defective phytohemagglutinin-induced T-cell mitogenesis. Likewise, their blastogenic response to CD3 monoclonal antibody was also depressed, although the DNA synthesis induced by stimulation with phorbol esters (12-O-tetradecanoil-phorbol-13-acetate) plus ionophore (ionomycin) was normal. These alterations could not be ascribed either to a decreased synthesis of interleukin-2 or to a defective expression of interleukin-2 receptor after cellular activation. Moreover, this defective proliferative response of T lymphocytes was observed even in the presence of saturating concentrations of exogenous interleukin-2. These results represent evidence of the deficiency in the interleukin-2-dependent pathway found in T lymphocytes from patients with primary biliary cirrhosis.
📜 SIMILAR VOLUMES
Interleukin-6 receptors (IL-6R) and interleukin-1 receptors (IL-1R) on lymphocyte surfaces were analyzed, using flow cytometry and dye-labeled IL-6 and IL-1β, to examine the clinical and immunological significance of these receptors. Incubation of peripheral blood mononuclear cells in the presence o
seven patients (three women and four men, mean age 49 years) who had no histological or biochemical signs of liver disease (specimens were obtained at laparotomy for conditions not affecting the liver); Abbreviations: PBC, primary biliary cirrhosis; UDCA, ursodeoxycholic acid; AE, anion (3) a second
Ursodeoxycholic acid (UDCA) is a safe and effective medical therapy for most patients with primary biliary cirrhosis (PBC). However, some patients show an incomplete response to UDCA therapy. Treatment with corticosteroids may be of benefit although at the expense of systemic side effects. Budesonid
Previous studies in which quantitative immunofluorescenm was used have shown that certain biliary epithelial cells in liver with primary biliary cirrhosis show i n d levels of pyruvate dehydrogenase dihyddipoamide acetyltransferase compared with controls. "his study was designed to determine whether